Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metapneumovirus”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT00265187
What this trial is testing

The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis.

Who this might be right for
Respiratory Tract InfectionChildren
HaEmek Medical Center, Israel 200
Testing effectiveness (Phase 2)Looking for participantsNCT06665100
What this trial is testing

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Who this might be right for
Hematologic MalignanciesHematopoietic Stem Cell Transplant (HSCT)
Pulmotect, Inc. 100
Early research (Phase 1)Active Not RecruitingNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Testing effectiveness (Phase 2)WithdrawnNCT03502694
What this trial is testing

Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus

Who this might be right for
Metapneumovirus
Janssen Research & Development, LLC
Early research (Phase 1)Study completedNCT01255410
What this trial is testing

Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine

Who this might be right for
Metapneumovirus
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT06850051
What this trial is testing

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Who this might be right for
Healthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more
Sanofi 270
Early research (Phase 1)Active Not RecruitingNCT06556147
What this trial is testing

RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults

Who this might be right for
Healthy Volunteers
Vicebio Australia Proprietary Limited 144
Testing effectiveness (Phase 2)Ended earlyNCT04933968
What this trial is testing

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Who this might be right for
Respiratory Tract Viral InfectionsHuman Metapneumovirus (hMPV) InfectionParainfluenza (PIV) Infection+2 more
AlloVir 17
Not applicableUnknownNCT00613184
What this trial is testing

Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses

Who this might be right for
Respiratory Syncytial VirusHuman MetapneumovirusInfluenza+2 more
Kern Medical Center 150
Testing effectiveness (Phase 2)Study completedNCT06134648
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersHuman Metapneumovirus
Sanofi Pasteur, a Sanofi Company 646
Early research (Phase 1)Study completedNCT01109329
What this trial is testing

Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults

Who this might be right for
Human Metapneumovirus
National Institute of Allergy and Infectious Diseases (NIAID) 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654
What this trial is testing

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Who this might be right for
Human Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 1,530
Early research (Phase 1)Study completedNCT04144348
What this trial is testing

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 51
Not applicableEnded earlyNCT04431050
What this trial is testing

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens

Who this might be right for
Human InfluenzaRespiratory Syncytial Virus InfectionsRhinoviral Infections+3 more
Imperial College London 6
Early research (Phase 1)Study completedNCT06583031
What this trial is testing

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

Who this might be right for
RSV InfectionhMPV
Sanofi Pasteur, a Sanofi Company 385
Not applicableStudy completedNCT06309212
What this trial is testing

Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

Who this might be right for
The Prevalance of HMPV After COVID-19 PandemicThe Importance of Accurate Diagnosis for HPMV
Acibadem University 2,197
Testing effectiveness (Phase 2)Study completedNCT05903183
What this trial is testing

Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age

Who this might be right for
Healthy
Icosavax, Inc. 264
Not applicableStudy completedNCT02984280
What this trial is testing

Specific Respiratory Infections as Triggers of Acute Medical Events

Who this might be right for
Influenza, HumanRespiratory Syncytial Virus InfectionsParainfluenza+4 more
University College, London 787,000
Testing effectiveness (Phase 2)Study completedNCT06481579
What this trial is testing

IVX-A12 in Adults Participants

Who this might be right for
Healthy Participants
Icosavax, Inc. 143
Early research (Phase 1)Study completedNCT06237296
What this trial is testing

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection
Sanofi Pasteur, a Sanofi Company 558
Load More Results